The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
9 Meters Biopharma, Inc(NASDAQ:NMTR) 
9 Meters Biopharma, Inc., a clinical-stage biopharmaceutical company, focuses on patients with rare and unmet needs in gastroenterology. Its pipeline includes drug candidates for short bowel syndrome (SBS) and celiac disease, as well as for undisclosed rare diseases and/or unmet needs. The company i...
Website: http://www.innovatebiopharma.com/
Founded: 2012
CEO: Sandeep Laumas
Sector: Manufacturing
Industry: Computer Storage Device Manufacturing
Share this website to your friends
9 Meters Biopharma Op Cashflow Per Share ttm
9 Meters Biopharma Free Cashflow Per Share ttm
9 Meters Biopharma Cash Per Share ttm
9 Meters Biopharma (GAAP) P/E ratio ttm
9 Meters Biopharma P/B ratio ttm
No extra charts and metrics for this ticker.